94 related articles for article (PubMed ID: 8536681)
1. Human monoclonal antibodies to cytomegalovirus. Characterization and recombinant expression of a glycoprotein-B-specific antibody.
Böldicke T; Haase B; Böcher M; Lindenmaier W
Eur J Biochem; 1995 Dec; 234(2):397-405. PubMed ID: 8536681
[TBL] [Abstract][Full Text] [Related]
2. Bacterial expression of a neutralizing mouse monoclonal antibody Fab fragment to a 150-kilodalton surface antigen of Entamoeba histolytica.
Tachibana H; Takekoshi M; Cheng XJ; Maeda F; Aotsuka S; Ihara S
Am J Trop Med Hyg; 1999 Jan; 60(1):35-40. PubMed ID: 9988319
[TBL] [Abstract][Full Text] [Related]
3. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).
Britt WJ; Vugler L; Stephens EB
J Virol; 1988 Sep; 62(9):3309-18. PubMed ID: 2841483
[TBL] [Abstract][Full Text] [Related]
4. [Neutralizing human antibody specific for human cytomegalovirus in E. coli expression system].
Ihara S; Maeda F; Takekoshi M
Nihon Rinsho; 1998 Jan; 56(1):161-6. PubMed ID: 9465683
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner.
Ohta A; Fujita A; Murayama T; Iba Y; Kurosawa Y; Yoshikawa T; Asano Y
Microbes Infect; 2009 Nov; 11(13):1029-36. PubMed ID: 19651232
[TBL] [Abstract][Full Text] [Related]
6. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.
Funaro A; Gribaudo G; Luganini A; Ortolan E; Lo Buono N; Vicenzi E; Cassetta L; Landolfo S; Buick R; Falciola L; Murphy M; Garotta G; Malavasi F
BMC Biotechnol; 2008 Nov; 8():85. PubMed ID: 19014469
[TBL] [Abstract][Full Text] [Related]
7. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.
Cranage MP; Kouzarides T; Bankier AT; Satchwell S; Weston K; Tomlinson P; Barrell B; Hart H; Bell SE; Minson AC
EMBO J; 1986 Nov; 5(11):3057-63. PubMed ID: 3024973
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human IgG antibodies against human cytomegalovirus.
Duan T; Wang XF; Xiao SY; Gu SY; Liang MF
Biomed Environ Sci; 2008 Oct; 21(5):372-80. PubMed ID: 19133610
[TBL] [Abstract][Full Text] [Related]
9. Generation and Application of Mouse Monoclonal Antibody Against Human Cytomegalovirus UL23.
Li W; Chai H; Feng L; Deng J; Yang X; Ran Y; Li H
Viral Immunol; 2020 Jun; 33(5):378-383. PubMed ID: 32181702
[TBL] [Abstract][Full Text] [Related]
10. Bacterially expressed Fabs of monoclonal antibodies neutralizing tumour necrosis factor alpha in vitro retain full binding and biological activity.
Orfanoudakis G; Karim B; Bourel D; Weiss E
Mol Immunol; 1993 Nov; 30(16):1519-28. PubMed ID: 8232337
[TBL] [Abstract][Full Text] [Related]
11. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.
Urban M; Britt W; Mach M
J Virol; 1992 Mar; 66(3):1303-11. PubMed ID: 1371164
[TBL] [Abstract][Full Text] [Related]
12. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
13. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
[TBL] [Abstract][Full Text] [Related]
14. Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody.
Chandramouli S; Ciferri C; Nikitin PA; Caló S; Gerrein R; Balabanis K; Monroe J; Hebner C; Lilja AE; Settembre EC; Carfi A
Nat Commun; 2015 Sep; 6():8176. PubMed ID: 26365435
[TBL] [Abstract][Full Text] [Related]
15. An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies.
Marshall GS; Ricciardi RP; Rando RF; Puck J; Ge RW; Plotkin SA; Gönczöl E
J Infect Dis; 1990 Nov; 162(5):1177-81. PubMed ID: 2172396
[TBL] [Abstract][Full Text] [Related]
16. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
Tarar MR; Emery VC; Harrison TJ
FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):183-92. PubMed ID: 9116635
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies.
Meyer H; Sundqvist VA; Pereira L; Mach M
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2375-83. PubMed ID: 1383409
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal anti-HCMV neutralizing antibody from phage display libraries.
Takekoshi M; Maeda F; Tachibana H; Inoko H; Kato S; Takakura I; Kenjyo T; Hiraga S; Ogawa Y; Horiki T; Ihara S
J Virol Methods; 1998 Sep; 74(1):89-98. PubMed ID: 9763132
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
